- Home
- VEON vs VKTX Comparison
VEON vs VKTX Comparison
Compare VEON & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- VKTX
- Stock Information
- Founded
- VEON 1992
- VKTX 2012
- Country
- VEON United Arab Emirates
- VKTX United States
- Employees
- VEON N/A
- VKTX N/A
- Industry
- VEON Telecommunications Equipment
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- VKTX Health Care
- Exchange
- VEON Nasdaq
- VKTX Nasdaq
- Market Cap
- VEON 4.0B
- VKTX 3.5B
- IPO Year
- VEON 1996
- VKTX 2015
- Fundamental
- Price
- VEON $58.53
- VKTX $27.05
- Analyst Decision
- VEON Strong Buy
- VKTX Strong Buy
- Analyst Count
- VEON 1
- VKTX 13
- Target Price
- VEON $60.00
- VKTX $86.92
- AVG Volume (30 Days)
- VEON 242.7K
- VKTX 9.7M
- Earning Date
- VEON 08-07-2025
- VKTX 10-22-2025
- Dividend Yield
- VEON N/A
- VKTX N/A
- EPS Growth
- VEON N/A
- VKTX N/A
- EPS
- VEON 13.63
- VKTX N/A
- Revenue
- VEON $4,148,000,000.00
- VKTX N/A
- Revenue This Year
- VEON $10.26
- VKTX N/A
- Revenue Next Year
- VEON $7.02
- VKTX N/A
- P/E Ratio
- VEON $4.45
- VKTX N/A
- Revenue Growth
- VEON 7.27
- VKTX N/A
- 52 Week Low
- VEON $25.92
- VKTX $18.92
- 52 Week High
- VEON $64.00
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- VEON 55.18
- VKTX 40.23
- Support Level
- VEON $55.98
- VKTX $24.77
- Resistance Level
- VEON $63.29
- VKTX $26.65
- Average True Range (ATR)
- VEON 3.02
- VKTX 1.78
- MACD
- VEON -0.25
- VKTX -0.98
- Stochastic Oscillator
- VEON 31.80
- VKTX 20.19
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.